CONTINENTAL ADVISORS LLC

Position in PRGO — PERRIGO Co plc

CIK 1277779 Park City, UT

Back to PRGO Full portfolio

Position in PRGO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,494,367

+$309,487 QoQ

Shares Held

418,470

+39.2% QoQ

Ownership

0.302%

of shares outstanding

% of Portfolio

2.68%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PRGO Over Time

Shares Held

Position Value (USD)

Derivatives in PRGO

reported options exposure · as of Mar 31, 2026

CallValue

$3,071,640

CallShares

286,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CONTINENTAL ADVISORS LLC holds $23,793,973 across 3 Drug Manufacturers - Specialty & Generic names. PRGO ranks #3 (18.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	888,750	$12,007,012
2	TEVA	Teva Pharmaceutical Industries Ltd	242,118	$7,292,594
3	PRGO	PERRIGO Co plc This page	418,470	$4,494,367

All Filings in PRGO

Export CSV

34 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,071,640	286,000	-31.7%	Call	Sole	2026-05-15
2026-03-31	$4,494,367	418,470	+72.7%	Shares	Sole	2026-05-15
2025-12-31	$3,372,816	242,300	-19.4%	Call	Sole	2026-02-12
2025-12-31	$4,184,880	300,638	+17.3%	Shares	Sole	2026-02-12
2025-09-30	$5,707,934	256,306	+754.4%	Shares	Sole	2025-11-03
2025-09-30	$668,100	30,000	-79.3%	Call	Sole	2025-11-03
2025-06-30	$3,871,808	144,903	0.0%	Shares	Sole	2025-08-19
2025-03-31	$4,063,080	144,903	+260.5%	Shares	Sole	2025-05-16
2025-03-31	$1,127,208	40,200	-70.4%	Call	Sole	2025-05-16
2024-12-31	$3,494,066	135,903	+170.2%	Shares	Sole	2025-02-14
2024-12-31	$1,293,213	50,300	-71.6%	Call	Sole	2025-02-14
2024-09-30	$4,647,457	177,181	+37.6%	Shares	Sole	2024-11-14
2024-06-30	$3,306,762	128,768	-18.4%	Shares	Sole	2024-08-14
2024-03-31	$5,078,551	157,768	+19.0%	Shares	Sole	2024-05-15
2023-12-31	$4,268,097	132,632	+5.4%	Shares	Sole	2024-02-14
2023-09-30	$4,018,607	125,778	-8.7%	Shares	Sole	2023-11-14
2023-06-30	$4,677,563	137,778	-14.0%	Shares	Sole	2023-08-14
2023-03-31	$5,749,171	160,278	+11.9%	Shares	Sole	2023-05-15
2022-12-31	$4,884,347	143,278	+473.1%	Shares	Sole	2023-02-14
2022-12-31	$852,250	25,000	-82.1%	Call	Sole	2023-02-14
2022-09-30	$4,966,653	139,278	+178.6%	Shares	Sole	2022-11-14
2022-06-30	$2,028,500	50,000	-38.9%	Call	Sole	2022-08-15
2022-06-30	$3,321,303	81,866	-22.1%	Shares	Sole	2022-08-15
2022-03-31	$4,040,491	105,139	+50.2%	Shares	Sole	2022-05-16
2022-03-31	$2,690,100	70,000	-13.3%	Call	Sole	2022-05-16
2021-12-31	$3,140,747	80,739	+58.9%	Shares	Sole	2022-02-14
2021-12-31	$1,976,120	50,800	-26.6%	Call	Sole	2022-02-14
2021-09-30	$3,277,081	69,239	+27.7%	Shares	Sole	2021-11-15
2021-06-30	$2,486,858	54,239	+4.8%	Shares	Sole	2021-08-16
2021-03-31	$2,093,634	51,733	0.0%	Shares	Sole	2021-05-17
2020-12-31	$2,313,499	51,733	+40.8%	Shares	Sole	2021-02-16
2020-09-30	$1,686,412	36,733	0.0%	Shares	Sole	2020-11-16
2020-06-30	$2,030,232	36,733	0.0%	Shares	Sole	2020-08-14
2020-03-31	$1,766,489	36,733	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.